Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EI24 pseudogene 2 (EI24P2) is classified as a pseudogene in the human genome. Pseudogenes are DNA sequences that resemble functional genes but lack the ability to encode functional proteins due to mutations or deletions. EI24P2 is homologous to the EI24 gene, which is protein-coding and acts as a tumor suppressor, but EI24P2 itself does not produce a functional protein and does not serve as a druggable molecular target or biomarker[7]. There is no evidence for EI24P2 having a direct biological function, associated disease role, or interaction with drugs. It is annotated in genomic databases for research and comparative genomics, but it is not clinically actionable. If your intent was to find information on the active EI24 gene/protein, please refer to "EI24 autophagy-associated transmembrane protein," which is a protein-coding gene involved in autophagy and cell death signaling[1][3][4]. EI24P2, in contrast, is a non-coding pseudogene[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EI24 pseudogene 2 (EI24P2).